Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
about
Regular use of aspirin and pancreatic cancer risk.Regular aspirin use and lung cancer risk.Use of NSAIDs for the chemoprevention of colorectal cancerLong-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancerPretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expressionA population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirinRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyInhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humansEpithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease.Colorectal cancer: molecules and populations.Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.Meta-analyses of colorectal cancer risk factors.Aspirin dose and duration of use and risk of colorectal cancer in men.Are there two sides to colorectal cancer?Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study.Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisAcetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African AmericansRegular aspirin use and breast cancer risk in US Black women.Comparative efficacy of 5flourouracil/calcium leucovorine versus 5flourouracil/calcium leucovorine plus oxaliplatin in the adjuvant treatment of colonic carcinoma in Kashmir.Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs.Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma.Inhibitory Effect of Aspirin on Cholangiocarcinoma CellsRe: Trends in reported incidence of primary malignant brain tumors in children in the United States.Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats.Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
P2860
Q24801805-7A325547-2A49-4AEB-8892-32EFADDF941DQ24803838-31ACB0C7-D292-4102-8493-909050813A26Q28165741-08B04821-E791-4530-830B-3DAB30448FFBQ28188848-CE8A023D-C608-445F-A26C-300A60A9538EQ28192323-88EA555F-C262-4CDF-BC41-93A885F39260Q28195221-CB877531-3A7A-4290-9D16-C0700E7B5453Q28196301-1CFF183B-4437-4191-89C2-4A8440BDC5D4Q30486725-EF883F2F-7170-414A-A3F0-AF9408CC7936Q30545576-CBB37696-06BD-4930-AECB-212B2AF46C58Q30822060-C732E9BF-53F6-4E58-833A-CA6131A0B354Q33652932-E8948211-0371-4ECC-8E66-7292F6D85F5DQ34047699-1A088CDE-7B4D-4F5B-A5A0-7037AED26DA7Q34165563-C6027C47-4367-4E7E-827B-513B3AC8463EQ34584944-47DDEF76-9227-4F01-A0AC-08FFFF1C88DBQ34822109-7A6C95B7-7294-4F67-B090-1461363334FDQ35050873-E588470B-0590-4DA3-9C14-E53DE5CD7E9AQ35552253-D6AB2CD0-CCBB-4441-B133-25B5125A37A7Q35769876-A3AA4505-6A3C-4CC4-BF06-3AEBC933A701Q37078077-06984BD5-87DD-4DB4-8116-F5BEBD1A2EC4Q37191009-30F54040-E5D7-47F3-A9C3-9BCE15B36329Q37306239-139A3436-E1AA-483A-B59B-75FD5D55352FQ37324216-52206A78-2D2D-4652-A280-A9A10200B306Q37422332-3E176851-9BC7-4E7D-AC7E-F75F22E514CFQ37726379-A849B290-EB45-4765-A6B6-221274E057F8Q40605372-9FBCB33A-7B5A-4B4E-8FE4-804A284EFC9FQ47367905-0C605F5B-AB7C-4A8E-A123-CAF7DF1F64B1Q48192569-D6FDFE26-D76F-4071-AEFF-FC9C38BACE02Q53228950-77BD0561-D83E-452C-90D7-347595D98EC4Q53347864-7F7FC869-B968-4AD4-8C58-3FFAEF3F08D8Q55312563-84A53E25-1B15-457F-BE74-FE968CBA9C47Q58699234-B991BEAE-6D7D-41A2-BF4D-30D46C9763C6
P2860
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@en
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@nl
type
label
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@en
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@nl
prefLabel
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@en
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@nl
P2860
P1433
P1476
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q
P407
P577
1998-06-01T00:00:00Z